阿糖胞苷（NSC - 63878）和6 - 硫鸟嘌呤（NSC - 752）在携带实体L1210白血病肿瘤小鼠体内的处置情况。 - Suppr | 超能文献

Disposition of arabinosylcytosine (NSC-63878) and 6-THIOGUANINE (NSC-752) in solid L1210 leukemia tumor-bearing mice.

作者信息

Pittillo R F, Woolley C

出版信息

Cancer Chemother Rep. 1973 Sep-Oct;57(3):275-89.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Disposition of arabinosylcytosine (NSC-63878) and 6-THIOGUANINE (NSC-752) in solid L1210 leukemia tumor-bearing mice.

Cancer Chemother Rep. 1973 Sep-Oct;57(3):275-89.

2

Scheduling of arabinosylcytosine and 6-thioguanine therapy.

Cancer Res. 1973 May;33(5):946-9.

3

Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.

Cancer Chemother Rep. 1971 Dec;55(5):547-55.

4

Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.

Cancer Treat Rep. 1983 Jun;67(6):547-54.

5

Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.

Cancer Res. 1970 Aug;30(8):2166-72.

6

Combined effect of cytosine arabinoside and thiopurines.

Cancer Treat Rep. 1976 Dec;60(12):1925-34.

7

Determinants of Ara-C action: biochemical consideration.

Prog Clin Biol Res. 1983;132E:107-20.

8

Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).

Cancer Chemother Rep. 1973 Sep-Oct;57(3):291-8.

9

Studies on drug resistance. V. Combination chemotherapy with cytosine arabinoside (NSC-63878) plus 6-thioguanine (NSC-752) in cytosine arabinoside-sensitive and -resistant P815 mouse neoplasms.

Cancer Chemother Rep. 1973 Sep-Oct;57(3):349-51.

10

Biochemical aspects of drug combinations.

Cancer Chemother Rep 2. 1974 Mar;4(1):115-29.

引用本文的文献

1

6-thioguanine as a cause of toxic veno-occlusive disease of the liver.

J Clin Pathol. 1982 Oct;35(10):1086-91. doi: 10.1136/jcp.35.10.1086.

2

Interaction of 6-thioguanine and cytosine arabinoside in cultured cells from patients with acute myeloid leukaemia.

Br J Cancer. 1978 Nov;38(5):634-5. doi: 10.1038/bjc.1978.261.